NCT04781699View on ClinicalTrials.gov

Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation

UnknownOBSERVATIONAL
Enrollment

498

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

September 1, 2022

Conditions
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial InfarctionAcute Coronary SyndromeCoronary Heart DiseaseHeart Failure
Trial Locations (6)

NE24 1DX

RECRUITING

Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne

CF82 7GP

RECRUITING

Aneurin Bevan University Health Board, Ystrad Mynach

UB9 6JH

RECRUITING

Royal Brompton Hospital, London

S5 7AU

RECRUITING

Sheffield Teaching Hospitals, Sheffield

BT9 7AB

NOT_YET_RECRUITING

Belfast Health and Social Care Trust, Belfast

KA2 0BE

RECRUITING

NHS Ayrshire and Arran, Kilmarnock

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Northumbria Healthcare NHS Foundation Trust

OTHER

collaborator

NHS Ayrshire and Arran

OTHER

collaborator

Belfast Health and Social Care Trust

OTHER

collaborator

Aneurin Bevan University Health Board

OTHER

lead

Sheffield Hallam University

OTHER